Author:
Vögeli Alaadin,Ottiger Manuel,Meier Marc A.,Steuer Christian,Bernasconi Luca,Kulkarni Prasad,Huber Andreas,Christ-Crain Mirjam,Henzen Christoph,Hoess Claus,Thomann Robert,Zimmerli Werner,Mueller Beat,Schuetz Philipp
Funder
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Research Council of the Kantonsspital Aarau
Publisher
Springer Science and Business Media LLC
Reference46 articles.
1. Nickler M, Ottiger M, Steuer C, Huber A, Anderson JB, Muller B, Schuetz P. Systematic review regarding metabolic profiling for improved pathophysiological understanding of disease and outcome prediction in respiratory infections. Respir Res. 2015;16:125.
2. Scott JA, Duongh M, Young AW, Subbarao P, Gauvreau GM, Grasemann H. Asymmetric dimethylarginine in chronic obstructive pulmonary disease (ADMA in COPD). Int J Mol Sci. 2014;15(4):6062–71.
3. Shivkar RR, Abhang SA. Ratio of serum asymmetric dimethyl arginine (ADMA)/ nitric oxide in coronary artery disease patients. J Clin Diagn Res : JCDR. 2014;8(8):CC04–6.
4. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993;329(27):2002–12.
5. Maarsingh H, Pera T, Meurs H. Arginase and pulmonary diseases. Naunyn Schmiedebergs Arch Pharmacol. 2008;378(2):171–84.